269 related articles for article (PubMed ID: 29028555)
21. Prevalence and Correlates of Past Year Ecstasy/MDMA Use in the United States.
Yang KH; Kepner W; Nijum A; Han BH; Palamar JJ
J Addict Med; 2023 Sep-Oct 01; 17(5):592-597. PubMed ID: 37788615
[TBL] [Abstract][Full Text] [Related]
22. Patterns of ecstasy use in Australia: findings from a national household survey.
Degenhardt L; Barker B; Topp L
Addiction; 2004 Feb; 99(2):187-95. PubMed ID: 14756711
[TBL] [Abstract][Full Text] [Related]
23. Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions.
Matthews AJ; Bruno R; Dietze P; Butler K; Burns L
Drug Alcohol Depend; 2014 Nov; 144():218-24. PubMed ID: 25282306
[TBL] [Abstract][Full Text] [Related]
24. The external validity of results derived from ecstasy users recruited using purposive sampling strategies.
Topp L; Barker B; Degenhardt L
Drug Alcohol Depend; 2004 Jan; 73(1):33-40. PubMed ID: 14687957
[TBL] [Abstract][Full Text] [Related]
25. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.
Wu LT; Schlenger WE; Galvin DM
Drug Alcohol Depend; 2006 Sep; 84(1):102-13. PubMed ID: 16483730
[TBL] [Abstract][Full Text] [Related]
26. It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees.
Yacoubian GS; Boyle C; Harding CA; Loftus EA
J Drug Educ; 2003; 33(2):187-96. PubMed ID: 12929709
[TBL] [Abstract][Full Text] [Related]
27. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
Parrott AC; Milani RM; Parmar R; Turner JD
Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
[TBL] [Abstract][Full Text] [Related]
28. Mental disorders in ecstasy users: a prospective-longitudinal investigation.
Lieb R; Schuetz CG; Pfister H; von Sydow K; Wittchen H
Drug Alcohol Depend; 2002 Oct; 68(2):195-207. PubMed ID: 12234649
[TBL] [Abstract][Full Text] [Related]
29. The rise of new psychoactive substance use in Australia.
Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
[TBL] [Abstract][Full Text] [Related]
30. Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene.
Palamar JJ; Salomone A; Gerace E; Di Corcia D; Vincenti M; Cleland CM
Int J Drug Policy; 2017 Oct; 48():91-98. PubMed ID: 28810159
[TBL] [Abstract][Full Text] [Related]
31. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
Parrott AC; Sands HR; Jones L; Clow A; Evans P; Downey LA; Stalder T
Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
[TBL] [Abstract][Full Text] [Related]
32. MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.
Jones GM; Nock MK
J Psychopharmacol; 2022 Jan; 36(1):46-56. PubMed ID: 34983249
[TBL] [Abstract][Full Text] [Related]
33. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
[TBL] [Abstract][Full Text] [Related]
34. The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users.
Davis AK; Rosenberg H
J Psychoactive Drugs; 2014; 46(2):154-61. PubMed ID: 25052792
[TBL] [Abstract][Full Text] [Related]
35. Polysubstance use and its correlates in adolescent ecstasy users in Taiwan.
Yen CF; Hsu SY; Cheng CP
Addict Behav; 2007 Oct; 32(10):2286-91. PubMed ID: 17314013
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City.
Palamar JJ; Barratt MJ
Drug Alcohol Rev; 2019 Jan; 38(1):42-49. PubMed ID: 30575155
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.
Licht CL; Christoffersen M; Okholm M; Damgaard L; Fink-Jensen A; Knudsen GM; Erritzoe D
Hum Psychopharmacol; 2012 Jul; 27(4):352-63. PubMed ID: 22696164
[TBL] [Abstract][Full Text] [Related]
38. Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users.
Uosukainen H; Tacke U; Winstock AR
Int J Drug Policy; 2015 Jan; 26(1):78-83. PubMed ID: 25107829
[TBL] [Abstract][Full Text] [Related]
39. Shifting characteristics of nonmedical prescription tranquilizer users in the United States, 2005-2014.
Palamar JJ; Han BH; Martins SS
Drug Alcohol Depend; 2019 Feb; 195():1-5. PubMed ID: 30553910
[TBL] [Abstract][Full Text] [Related]
40. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran.
Nikfarjam A; Shokoohi M; Shahesmaeili A; Haghdoost AA; Baneshi MR; Haji-Maghsoudi S; Rastegari A; Nasehi AA; Memaryan N; Tarjoman T
Int J Drug Policy; 2016 May; 31():147-52. PubMed ID: 26980349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
